791118-91-7

Basic information

• Product Name: 3-[2-(trifluoromethyl)-α-(2,3-dihydrobenzo[1,4]dioxin-6-yl)benzyloxy]azetidine
• Synonyms: 3-[2-(trifluoromethyl)-α-(2,3-dihydrobenzo[1,4]dioxin-6-yl)benzyloxy]azetidine
• CAS NO: 791118-91-7
• Molecular Weight: 365.352
• Mol File: 791118-91-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[2-(trifluoromethyl)-α-(2,3-dihydrobenzo[1,4]dioxin-6-yl)benzyloxy]azetidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-(trifluoromethyl)-α-(2,3-dihydrobenzo[1,4]dioxin-6-yl)benzyloxy]azetidine(791118-91-7)
• EPA Substance Registry System: 3-[2-(trifluoromethyl)-α-(2,3-dihydrobenzo[1,4]dioxin-6-yl)benzyloxy]azetidine(791118-91-7)

Safety Data

• Hazardous Substances Data: 791118-91-7(Hazardous Substances Data)

Relevant articles and documents

AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDRS

Compounds of formula (I) and their use in therapy, particularly for the treatment of a disorder mediated by CB1 receptors, such as obesity, wherein: R1 is aryl or heteroaryl; R2 is alkyl, aryl or heteroaryl; R3 is alkyl, aryl, heteroaryl, NR9R10, OR 15, or NR16C(O)R17;Y is C=O, C=S, SO2, or (CR7R8)p; m = 1 or 2; n = 1 or 2; and p=1,2,3 or 4, R7 to R17 being as defined in the specification; wherein if -Y-R3 is -C(O)NH(alkyl) then: R1 and/or R2 is selected from heteroary1; and/or m and/or n is 2; and/or R11 and/or R12 is lower alkyl, or a pharmaceutically acceptable salt or prodrug thereof.